-
Clorox (CLX) PT Lowered to $147 at BMO Capital
-
Buy Clorox (CLX) on Today's Weakness - BMO
-
BMO Capital Starts Clorox (CLX) at Outperform
-
Notable Analyst Rating Changes 06/01: (S) (LAZ) (CLX) Upgraded; (LEAP) (KSS) (TS) Downgraded
-
Notable Analyst Rating Changes 04/08: (AER) (CVS) (BJ) Upgraded; (SWY) (CLX) (COST) Downgraded
-
Notable Analyst Rating Changes 4/22: F, CAT, BRCD, FDX Upgraded; NBR, CCO, HAL, WFR, FITB Downgraded
-
Notable Analyst Rating Changes 11/14: CLX, LDK, ALO, URBN Upgraded; GSK, EMR, LHO, UDR Downgraded
-
BMO Capital Downgrades Clorox (CLX) to Market Perform
-
Notable Analyst Rating Changes 2/6: TMA, BWLD, BSX Upgraded; F, GM, CLX, YHOO Downgraded
-
Notable Analyst Rating Changes 1/16: INTC, Q, AKS, CLX Upgraded; VOD, CAB, INTC Downgraded
-
BMO Capital Upgrades Clorox (CLX) to Outperform